Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Chemotherapy|January 1, 1982
A new model of experimental Bacteroides fragilis infection in mice and ratsM Berti, E Rossi, G Candiani, et al.The American Review of Respiratory Disease|October 1, 1988
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose studyG Acocella, A Nonis, G Gialdroni-Grassi, et al.Il Farmaco; Edizione Scientifica|June 1, 1979
Synthesis and biological activities of some indolo[2,3-c]isoquinoline derivativesG Winters, N Di Mola, M Berti, et al.Arzneimittel-Forschung|July 1, 1977
1-Methyl-2-nitroimidazol-5-yl derivatives. IVth CommunicationB Cavalleri, G Volpe, V Arioli, et al.Antimicrobial Agents and Chemotherapy|October 1, 1984
In vitro activity of A-16686, a potential antiplaque agentR Pallanza, R Scotti, G Beretta, et al.The American Review of Respiratory Disease|September 1, 1985
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration studyG Acocella, R Conti, M Luisetti, et al.Minerva Stomatologica|July 1, 1994
[Deep rotated connective tissue flap for the reconstruction of the interdental papilla]H Aubert, G Bertrand, S Orlando, et al.The American Review of Respiratory Disease|December 1, 1985
The penetration of rifampicin, pyrazinamide, and pyrazinoic acid into mouse macrophagesG Acocella, N A Carlone, A M Cuffini, et al.The Journal of Antibiotics|April 1, 1984
A-16686, a new antibiotic from Actinoplanes. II. Biological propertiesR Pallanza, M Berti, R Scotti, et al.Journal of Medicinal Chemistry|August 1, 1978
Synthesis and biological activity of new 2-nitroimidazole derivativesB Cavalleri, G Volpe, V Arioli, et al.Pageof 5